A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treating Concussion
June 02, 2021 07:30 ET | Odyssey Group International
Irvine, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Improve Clinical Outcomes and Molecular Biomarkers in Parkinson’s Disease Patients
June 02, 2021 07:30 ET | electroCore, Inc.
ROCKAWAY, N.J., June 02, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper,...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Present at Investor Conferences in June
May 26, 2021 07:30 ET | electroCore, Inc.
ROCKAWAY, NJ, May 26, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced today that its management team will present a several...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Announces Successful Toxicology Studies for its Concussion Drug
May 26, 2021 07:29 ET | Odyssey Group International
IRVINE, CA, May 26, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International, Inc. Schedules Annual Meeting of Stockholders
May 24, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, May 24, 2021 (GLOBE NEWSWIRE) -- – Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Announces Completion of Novel Device for Nasal Delivery of Concussion Drug Candidate
May 19, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, May 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Welcomes Global Operations and Quality Leader Ricky Richardson to Board of Directors
May 13, 2021 08:05 ET | Odyssey Group International
IRVINE, CA, May 13, 2021 (GLOBE NEWSWIRE) --  Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Welcomes Dr Bob Arnot to Scientific Advisory Board
May 11, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, May 11, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),a technology and asset acquisition company focused on developing unique,...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces First Quarter 2021 Financial Results
May 06, 2021 16:12 ET | electroCore, Inc.
Record First quarter 2021 net sales of $1.2 million, increased 64% over first quarter 2020 and 30% sequentially Company to host a conference call and webcast today, May 6, 2021 at 4:30 pm ET ...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire™ (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic Headache
May 04, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, May 04, 2021 (GLOBE NEWSWIRE) -- -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the U.S. Department of Veterans Affairs is...